REDHILL BIOPHARMA LTD. Research and Development Expense
REDHILL BIOPHARMA LTD. (RDHL) reported Research and Development Expense of $964.00 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-09-05
- REDHILL BIOPHARMA LTD. research and development expense for the quarter ending 2022-06-30 was $1.47M, a 85.75% decline year-over-year.
- REDHILL BIOPHARMA LTD. research and development expense for the quarter ending 2021-06-30 was $10.33M, a 221.34% increase year-over-year.
- REDHILL BIOPHARMA LTD. research and development expense for the quarter ending 2020-06-30 was $3.21M, a 53.90% decline year-over-year.
- REDHILL BIOPHARMA LTD. research and development expense for the quarter ending 2019-06-30 was $6.97M, a 15.35% increase year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2025-06-30 | $964.00K 6-K · filed 2025-09-05 | ||
| 2024-12-31 | $1.59M 20-F · filed 2025-04-10 | ||
| 2024-06-30 | $659.00K 6-K · filed 2025-09-05 | ||
| 2023-12-31 | $3.53M 20-F · filed 2025-04-10 | ||
| 2023-06-30 | $2.33M 6-K · filed 2024-08-29 | ||
| 2022-12-31 | $7.28M 20-F · filed 2025-04-10 | ||
| 2022-06-30 | $1.47M 6-K · filed 2022-11-07 | $4.53M 6-K · filed 2023-08-17 | |
| 2021-12-31 | $29.50M 20-F · filed 2024-04-08 | ||
| 2021-06-30 | $10.33M 6-K · filed 2022-11-07 | $17.81M 6-K · filed 2022-11-07 | |
| 2020-12-31 | $16.49M 20-F · filed 2023-04-28 | ||
| 2020-06-30 | $3.21M 6-K · filed 2021-08-26 | $5.98M 6-K · filed 2021-08-26 | |
| 2019-12-31 | $17.42M 20-F · filed 2022-03-17 | ||
| 2019-06-30 | $6.97M 6-K · filed 2020-08-13 | $12.34M 6-K · filed 2020-08-13 | |
| 2018-12-31 | $24.86M 20-F · filed 2021-03-18 | ||
| 2018-06-30 | $6.04M 6-K · filed 2019-07-23 | $12.46M 6-K · filed 2019-07-23 | |
| 2017-12-31 | $32.97M 20-F · filed 2020-03-04 | ||
| 2017-06-30 | $8.43M 6-K · filed 2018-08-30 | $16.57M 6-K · filed 2018-08-30 | |
| 2016-12-31 | $25.24M 20-F · filed 2019-02-26 | ||
| 2015-12-31 | $17.77M 20-F · filed 2018-02-22 |